ONWARD MEDICAL BV EO -12 (63E) - Total Liabilities
Based on the latest financial reports, ONWARD MEDICAL BV EO -12 (63E) has total liabilities worth €29.24 Million EUR (≈ $34.18 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check 63E asset resilience ratio to evaluate the company's liquid asset resilience ratio.
ONWARD MEDICAL BV EO -12 - Total Liabilities Trend (2021–2025)
This chart illustrates how ONWARD MEDICAL BV EO -12's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see 63E total asset value.
ONWARD MEDICAL BV EO -12 Competitors by Total Liabilities
The table below lists competitors of ONWARD MEDICAL BV EO -12 ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
MPC Münchmeyer Petersen Capital AG
F:MPCK
|
Germany | €21.91 Million |
|
Gansu Mogao Industrial Development Co Ltd
SHG:600543
|
China | CN¥332.99 Million |
|
Sidus Space Inc
NASDAQ:SIDU
|
USA | $4.24 Million |
|
Korea Information & Communications Co. Ltd
KQ:025770
|
Korea | ₩287.10 Billion |
|
Ming Shing Group Holdings Limited Ordinary Shares
NASDAQ:PMA
|
USA | $10.65 Million |
|
Salmon Evolution Holding AS
OL:SALME
|
Norway | Nkr2.50 Billion |
|
First Hotel Co Ltd
TW:2706
|
Taiwan | NT$1.67 Billion |
|
Malayan Flour Mills Bhd
KLSE:3662
|
Malaysia | RM922.77 Million |
Liability Composition Analysis (2021–2025)
This chart breaks down ONWARD MEDICAL BV EO -12's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See ONWARD MEDICAL BV EO -12 (63E) balance sheet quality index to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 6.67 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.53 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.35 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how ONWARD MEDICAL BV EO -12's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for ONWARD MEDICAL BV EO -12 (2021–2025)
The table below shows the annual total liabilities of ONWARD MEDICAL BV EO -12 from 2021 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | €29.24 Million ≈ $34.18 Million |
+4.11% |
| 2024-12-31 | €28.08 Million ≈ $32.83 Million |
+9.28% |
| 2023-12-31 | €25.70 Million ≈ $30.04 Million |
+7.24% |
| 2022-12-31 | €23.96 Million ≈ $28.01 Million |
+8.36% |
| 2021-12-31 | €22.11 Million ≈ $25.85 Million |
-- |
About ONWARD MEDICAL BV EO -12
Onward Medical N.V., a medical technology company, develops and commercializes therapies to enable functional recovery for people with Spinal Cord Injury (SCI). The company engages in developing ARCEX, a technology to enhance hand strength and sensation for individuals with SCI; ARCIM, a spinal cord stimulation system designed to address blood pressure instability and other symptoms in people wit… Read more